_______________________________________________
Press mailing list
[email protected]
https://lists-riik.eesti.ee/listinfo/press
Tere!
Palun see deltas registreerida, ma praegu ei leidnud, et see seal olemas oleks.
Tänud!
Kati
From: Triin Uusberg
Sent: Tuesday, July 31, 2018 11:17 AM
To: Kati Keel <
[email protected]>
Subject: FW: [Press] Invitation from The Economist - War on Cancer Europe - Minister Riina Sikkut
Vt. ega see pole maha kukkunud, st. on regatud ja mingi seisukoht võetud.
T
From: Karin Volmer
Sent: Wednesday, July 25, 2018 2:26 PM
To: Triin Uusberg <
[email protected]>; Eneli Mikko <
[email protected]>; Juhan-Mart Salumäe
<
[email protected]>
Subject: FW: [Press] Invitation from The Economist - War on Cancer Europe - Minister Riina Sikkut
Selline kutse Riinale. Annan otsa teile üle.
Tervitab
Karin
From: Argo Kerb <
[email protected]>
Sent: Wednesday, July 25, 2018 2:24 PM
To: SM Pressiesindajad <
[email protected]>
Cc:
[email protected]
Subject: FW: [Press] Invitation from The Economist - War on Cancer Europe - Minister Riina Sikkut
Tere
Edastan meie pressilisti tulnud kutse minister Sikkutile. Palun saatke õigesse kohta.
Tervitades
Argo
From: Press <
[email protected]> On Behalf Of Pranav Jain
Sent: Wednesday, July 25, 2018 12:31 PM
To:
[email protected]
Subject: [Press] Invitation from The Economist - War on Cancer Europe - Minister Riina Sikkut
Dear Minister Sikkut,
On behalf of Vivek Muthu, chair, The Economist Intelligence Unit Healthcare, we are
delighted to invite you to speak at the fourth iteration of the War on Cancer - Europe on
November 20th 2018 in London. Despite significant strides in prevention and in
survivorship, cancer remains a leading cause of death across Europe. With nearly 200
variations of cancer, the complexity of navigating treatments and optimising resources
has risen to the forefront of public debate. Technological innovations--from AI, to
wearables, to advancements in immunotherapy, to CAR-T and radiotherapy treatments,
are rapidly redefining patient experiences.
Now in its fourth year, War On Cancer Europe 2018, is part of our global series to
catalyse fresh debate around strengthening cancer control. The event will bring together
clinicians, patients, service providers, industry representatives, employers and
policymakers.
The Economist Events' reputation for intellectual integrity and clarity allows us to attract
an audience of senior decision-makers to our meetings, and we are looking forward to a
productive summit this coming spring.
Some of the speakers confirmed for the event are as follows, a full list of speakers can
be gleaned from the attached agenda:
Bengt Jonsson, professor emeritus of health economics, Stockholm School of Economics
Jan Geissler, director, European Patients’ Academy on Therapeutic Innovation (EUPATI)
Giske Ursin, director, Norwegian Cancer Registry
Neil Bacon, founder, iWantGreatCare
Belén Garijo, member of the executive board, chief executive officer healthcare, Merck
Sarunas Narbutas, president, Lithuanian Cancer Patient Coalition
I hope your diary will allow you to accept our invitation. Should you wish to discuss this
speaking role or the event further, I would be happy to schedule a call with you or a
member of your team to answer any questions. I look forward to hearing from you soon
and hopefully to welcoming you to the event in November.
Regards,
Pranav Jain
--
Pranav Jain
Programme Assistant
The Economist Group
12th Floor, Tower 9B, DLF Cyber City,
Phase III, Gurgaon - 122022, Haryana
Work line: +91 124 640 9384
Mobile: +91 7838 333 602
W Economist Events
Follow us on twitter @EconomistEvents
This e-mail may contain confidential material. If you are not an intended recipient, please notify the sender and delete all copies. It
may also contain personal views which are not the views of The Economist Group. We may monitor e-mail to and from our network.
Sent by a member of The Economist Group. The Group's parent company is The Economist Newspaper Limited, registered in
England with company number 236383 and registered office at The Adelphi, 1-11 John Adam Street, London, WC2N 6HT. For Group
company registration details go to http://legal.economistgroup.com
War On Cancer Europe 2018
The technological revolution and the future of patient engagement
November 20th 2018 ∙ London
Despite significant strides in prevention and in survivorship, cancer remains a
leading cause of death across Europe. With nearly 200 variations of cancer, the
complexity of navigating treatments and optimising resources has risen to the
forefront of public debate. Technological innovations--from AI, to wearables, to
advancements in immunotherapy, to CAR-T and radiotherapy treatments, are
rapidly redefining patient experiences.
As the digital revolution accelerates, the opportunities for patients to take
ownership of their diagnosis, treatments and oncology journey have grown.
How will current data privacy laws such as GDPR impact patient treatments?
How can stakeholders work collaboratively to ensure patient engagement is
more than a moral imperative but a tool for driving progress in oncology care?
Will increased patient access to data strengthen relationships with clinicians or
create new tensions for care? What can be learned from regions in Europe like
the Nordics, that are taking the lead on meaningful patient collaboration and
engagement with emerging technologies? How can patient engagement
strengthen drug discovery, R&D and regulation?
Now in its fourth year, War On Cancer Europe 2018, is part of our global series to
catalyse fresh debate around strengthening cancer control. The event will
bring together clinicians, patients, service providers, industry representatives,
employers and policymakers.
Conference chair:
Vivek Muthu, chair, The Economist Intelligence Unit Healthcare
© 2018 The Economist Events
This is a confidential draft programme for the conference mentioned in this document. All topics and speakers are indicative and subject
to change.
8.00 am Registration and refreshments
8.50 am Chairman’s opening remarks
9.00 am Setting the scene
Advances in medical technology and the promise of big data analysis
places patients, researchers and clinicians at a turning point in cancer
research, diagnosis and treatment. Innovations in AI and wearables are
heralded as reinvigorating patient engagement, but the long-term
potential of these emerging technologies is to be decided. Patients are
inheriting greater autonomy over how their personal information is shared
and retained, but to what degree will this shift the clinician/patient
relationship dynamic and empower patients?
Hospitals and providers already face tight cost constraints, so how will new
resource allocation priorities and the challenge of managing efficient
data systems impact the quality of cancer care? With many patients
travelling across Europe for treatments, will differences in implementing
patient data guidelines create tensions for quality care and which
stakeholders will be most affected? For stakeholders in oncology, GDPR
means that any organization handling the data of an EU citizen must be
ready for a new era of healthcare compliance to safeguard patient
information. This backdrop of evolving regulation coupled with a rise in
cybersecurity attacks like the NHS data breach ‘WannaCry’, are
challenging organizations to weigh new risks for patient care.
Speakers:
Jan Geissler, director, European Patients’ Academy on Therapeutic
Innovation (EUPATI)
Bengt Jonsson, professor emeritus of health economics, Stockholm School
of Economics
Elizabeth Barrett, chief executive officer, Novartis Oncology
9.40 am Research presentation from the EIU: Cancer Preparedness Index
The Economist Intelligence Unit will present the results of its current
research.
10.00 am Discussion of the Cancer Preparedness Index
10.40 am Networking break
11.10 am Digital technologies: strengthening infrastructure and patient care
© 2018 The Economist Events
This is a confidential draft programme for the conference mentioned in this document. All topics and speakers are indicative and subject
to change.
Oncology thought leaders across Europe are leveraging data platforms to
improve patient diagnosis, treatment and care. From the Nordic genomic
databases, to NHS digital health initiatives, to Iceland’s cancer registry,
which countries are outpacing the rest in infrastructure development? This
panel will convene experts across Europe to discuss case studies on digital
innovation and the impact on cancer care.
Speakers:
Belén Garijo, member of the executive board, chief executive,
healthcare, Merck
Giske Ursin, director, Norwegian Cancer Registry
Szabolcs Nagy, co-founder and chief executive officer, Turbine
11.50 am Debate: promises and pitfalls of patient access to data
Two experts will debate the proposition: this house believes the benefits of
data sharing for researchers, clinicians and patients outweigh the risks of
data breaches and privacy violations.
Speakers:
Neil Bacon, founder, iWantGreatCare
12.20 am Power of online platforms and demographic divides
Patient support groups, diagnosis and clinician follow ups are being
reinvented through digital channels. Enabled by social media, mobile
technologies and online platforms, what will the future of patient
communities and engagement with stakeholders look like? Is online
overblown and will younger generations have a competitive advantage
on leveraging resources, compared to older generations who did not
grow up in the digital age?
Speakers:
Sarunas Narbutas, president, Lithuanian Cancer Patient Coalition
Shafi Ahmed,chief medical officer, Medical Realities
1.00 pm Lunch and networking
2.00 pm Strategy sessions (Concurrent)
Radiation Oncology
What are the latest game-changing technologies in radiology and are
they meeting patient objectives? What is the patient’s role in
strengthening efficacy of future initiatives? What are the largest barriers to
© 2018 The Economist Events
This is a confidential draft programme for the conference mentioned in this document. All topics and speakers are indicative and subject
to change.
taking promising innovations to scale?
Breakthrough therapies and the technology for treatment in 2020
Sponsored by Novartis. What are the breakthroughs, from CAR-T to
dendritic cell therapies that are reinventing the future of patient
treatments? What is the scope for taking these therapies to scale and
what will future financing of these initiatives look like?
3.00 pm In conversation: one on one interview
In 2016, The Royal Marsden Trust announced the Cancer Taskforce’s Five
Year Strategy plan, which included investment in cancer prevention,
earlier diagnosis, technology and support for cancer survivors. How far
have initiatives come since inception in 2016? What are the largest
challenges in the road ahead and the implications for patient
engagement?
3.30 pm Networking break
4.00 pm Inequitable access: global contexts and socio economic divides
Universal healthcare coverage in Europe may cover procedures, but
consumer health technology remains an out of pocket expense. Could
technology worsen the divide between low-income and high income
countries’ access to care or finally be the great equalizer?
Speakers:
Maha El Rabbat, executive director , MENA Health Policy Forum
Sneh Khemka, president of population health, Aetna
4.40 pm In conversation: Economist editors compare findings from WOC Asia,
London and Dubai
This panel discussion will convene The Economist group healthcare editors
to discuss and highlight key oncology trends in Asia, Dubai and London. It
will be an interactive session with audience Q&A.
5.00pm Chair’s closing remarks
5.15pm Conference close
© 2018 The Economist Events
This is a confidential draft programme for the conference mentioned in this document. All topics and speakers are indicative and subject
to change.